Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hydroxysteroid dehydrogenase 6 pseudogene (LOC390332, ENSG00000278399) is a genomic sequence similar in structure to the protein-coding HSD17B6 gene but does not encode a functional protein. It lacks the ability to catalyze steroid hormone conversions or be involved in canonical steroid metabolism. As a pseudogene, it is not considered a valid molecular drug target, does not participate in biological functions or disease mechanisms, and has no associated drugs, mechanisms, or biomarkers. When referencing therapeutic targets or molecular functions in steroid metabolism, the canonical entity is "Hydroxysteroid 17-beta dehydrogenase 6" (HSD17B6), not the pseudogene[3][4][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hydroxysteroid dehydrogenase 6 pseudogene.